This technology introduces DNA-based "nanoswitches"—innovative nanostructures that enable precise and efficient detection of target analytes through conformational changes.
Background: Accurate detection of specific molecules, such as DNA sequences or other analytes, is fundamental in medical diagnostics, environmental monitoring, and biochemical research. Traditional detection methods often face challenges such as limited sensitivity, high cost, or slow processing times. To address these issues, researchers developed DNA nanostructures capable of responding to target molecules with measurable changes, aiming to create a detection system that is both highly specific and efficient.
Technology Overview: The core innovation involves "nanoswitches," which are specially engineered DNA nanostructures formed from single-stranded oligonucleotides. These nanoswitches switch between looped (on) and unlooped (off) states depending on the presence of specific target molecules. When a target analyte binds to the nanoswitch, it induces a conformational shift that can be detected through established laboratory techniques such as gel electrophoresis, nanopore analysis, or fluorescence analysis. What sets this technology apart is its ability to precisely detect a wide variety of analytes with exceptional sensitivity and specificity. The conformational change acts as a clear molecular signal indicating the presence or absence of the target. Moreover, the design allows for multiplexed detection—meaning multiple targets can be identified simultaneously within a single sample. The system is also cost-effective and adaptable, lending itself to rapid detection scenarios where timely results are critical. Experimental validation within the patent demonstrates the nanoswitches' capability to identify specific DNA sequences and mismatch variants, underscoring their potential utility across multiple domains.
https://suny.technologypublisher.com/files/sites/adobestock_237602801.jpeg Photo for reference only, not a depiction of the invention.
Advantages: • High specificity and sensitivity for detecting target molecules, minimizing false positives and negatives. • Rapid detection, enabling timely diagnostic and monitoring decisions. • Cost-effective composition, leveraging simple DNA oligonucleotides without requiring complex hardware. • Capability for multiplexed detection, allowing simultaneous analysis of multiple analytes. • Versatility in detection methods, compatible with common laboratory techniques such as fluorescence and gel electrophoresis. • Robust experimental validation confirms reliability and practical applicability.
Applications: • Medical diagnostics, including genetic testing and disease marker identification. • Environmental monitoring for detecting pollutants, pathogens, or other chemical analytes. • Biochemical research tools for analyzing DNA sequences, mutations, and molecular interactions. • Point-of-care testing where rapid and accurate detection is essential. • Multiplexed assay development, useful in situations requiring simultaneous detection of multiple targets.
Intellectual Property Summary: Issued patent 12,077,807
Stage of Development: TRL 5
Licensing Status: This technology is available for licensing.